Revolution Medicines, Inc. files 424B5

This filing is a prospectus supplement for Revolution Medicines, Inc. offering $500,000,000 aggregate principal amount of 0.50% convertible senior notes due 2033. The notes are senior, unsecured obligations of the company and are convertible into shares of Revolution Medicines' common stock under certain conditions.